(18F)fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 1, 2013, Pages 142-147

  Yasuda, Koichi ^a   Onimaru, Rikiya ^a   Okamoto, Shozo ^a   Shiga, Tohru ^a   Katoh, Norio ^a   Tsuchiya, Kazuhiko ^a   Suzuki, Ryusuke ^a   Takeuchi, Wataru ^c   Kuge, Yuji ^b   Tamaki, Nagara ^a   Shirato, Hiroki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HITACHI LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAINSTEM; CONTROL GROUPS; DEPTH OF INTERACTIONS; DOSE DISTRIBUTIONS; DOSE ESCALATION; GROSS TUMOR VOLUME; INTENSITY-MODULATED RADIATION THERAPY; MALIGNANT TUMORS; NASOPHARYNGEAL CANCER; PET SCAN; THRESHOLD DOSE;

DISEASES; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; SEMICONDUCTOR DETECTORS; TUMORS;

PHYSICAL THERAPY;

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; DIAGNOSTIC AGENT; DRUG DERIVATIVE; LUTETIUM; LUTETIUM ORTHOSILICATE; MISONIDAZOLE; RADIOPHARMACEUTICAL AGENT; SILICATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NASOPHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE ESCALATION; SEMICONDUCTOR; TUMOR VOLUME; BRAIN TUMOR; CASE CONTROL STUDY; CELL HYPOXIA; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; IMAGE GUIDED RADIOTHERAPY; INSTRUMENTATION; LARYNX TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; NASOPHARYNX; NASOPHARYNX TUMOR; SCINTISCANNING; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL HYPOXIA; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LUTETIUM; MALE; MIDDLE AGED; MISONIDAZOLE; MOUTH NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; SEMICONDUCTORS; SILICATES; THYROID NEOPLASMS;

EID: 84871396169     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.03.029     Document Type: Article

References (19)

1. L.H. Gray, A.D. Conger, and M. Ebert The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 26 312 1953 638 648
2. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 1 2005 18 24 (Pubitemid 41503384)
3. R.A. Popple, R. Ove, and S. Shen Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation Int J Radiat Oncol Biol Phys 54 3 2002 921 927
4. M.A. Hunt, M.J. Zelefsky, and S. Wolden Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer Int J Radiat Oncol Biol Phys 49 3 2001 623 632 (Pubitemid 32112190)
5. T.F. DeLaney Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center Technol Cancer Res Treat 6 suppl 4 2007 61 66
6. B. Gagel, P. Reinartz, and E. Dimartino pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'- deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia Strahlenther Onkol 180 10 2004 616 622 (Pubitemid 39361958)
7. K.S. Chao, W.R. Bosch, and S. Mutic A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 49 4 2001 1171 1182 (Pubitemid 32184623)
8. J.S. Rasey, N.J. Nelson, and L. Chin Characteristics of the binding of labeled fluoromisonidazole in cells in vitro Radiat Res 122 1990 301 308 (Pubitemid 20214420)
9. S.M. Bentzen, and V. Gregoire Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription Semin Radiat Oncol 21 2 2011 101 110
10. N.Y. Lee, J.G. Mechalakos, and S. Nehmeh Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study Int J Radiat Oncol Biol Phys 70 1 2008 2 13 (Pubitemid 350251039)
11. W. Choi, S.W. Lee, and S.H. Park Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer Radiother Oncol 97 2 2010 176 182
12. D. Thorwarth, S.M. Eschmann, and F. Paulsen Hypoxia dose painting by numbers: a planning study Int J Radiat Oncol Biol Phys 68 1 2007 291 300 (Pubitemid 46589864)
13. T. Shiga, Y. Morimoto, and N. Kubo A new PET scanner with semiconductor detectors enables better identification of intratumoral inhomogeneity J Nucl Med 50 1 2009 148 155
14. N. Katoh, K. Yasuda, and T. Shiga A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys. 82 4 2012 e671 e676 Epub 2012 Jan 13
15. Y. Morimoto, Y. Ueno, and W. Takeuchi Development of a 3D brain PET scanner using CdTe semiconductor detectors and its first clinical application IEEE Trans Nucl Sci 58 5 2011 2181 2189
16. D. Thorwarth, S.M. Eschmann, and F. Paulsen A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia Phys Med Biol 50 2005 2209 2224 (Pubitemid 40767811)
17. K. Hirata, S. Terasaka, and T. Shiga 18F-fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas Eur J Nucl Med Mol Imaging 39 5 2012 760 770
18. S.H. Yeh, R.S. Liu, and L.C. Wu Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma Eur J Nucl Med 23 10 1996 1378 1383
19. N. Lee, S. Nehmeh, and H. Schöder Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy Int J Radiat Oncol Biol Phys 75 1 2009 101 108